Literature DB >> 35734860

Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor.

Zhi Yuan Kok1,2, Leigh A Stoddart3,2, Sarah J Mistry1,2, Tamara A M Mocking4, Henry F Vischer4, Rob Leurs4, Stephen J Hill3,2, Shailesh N Mistry1, Barrie Kellam1,2.   

Abstract

The histamine H1 receptor (H1R) has recently been implicated in mediating cell proliferation and cancer progression; therefore, high-affinity H1R-selective fluorescent ligands are desirable tools for further investigation of this behavior in vitro and in vivo. We previously reported a H1R fluorescent ligand, bearing a peptide-linker, based on antagonist VUF13816 and sought to further explore structure-activity relationships (SARs) around the linker, orthostere, and fluorescent moieties. Here, we report a series of high-affinity H1R fluorescent ligands varying in peptide linker composition, orthosteric targeting moiety, and fluorophore. Incorporation of a boron-dipyrromethene (BODIPY) 630/650-based fluorophore conferred high binding affinity to our H1R fluorescent ligands, remarkably overriding the linker SAR observed in corresponding unlabeled congeners. Compound 31a, both potent and subtype-selective, enabled H1R visualization using confocal microscopy at a concentration of 10 nM. Molecular docking of 31a with the human H1R predicts that the optimized peptide linker makes interactions with key residues in the receptor.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35734860      PMCID: PMC9234962          DOI: 10.1021/acs.jmedchem.2c00125

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   8.039


  63 in total

1.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

2.  Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.

Authors:  Andrea J Vernall; Leigh A Stoddart; Stephen J Briddon; Hui Wen Ng; Charles A Laughton; Stephen W Doughty; Stephen J Hill; Barrie Kellam
Journal:  Org Biomol Chem       Date:  2013-09-14       Impact factor: 3.876

3.  Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H3 and H4 Receptors on Living Cells.

Authors:  Tamara A M Mocking; Eléonore W E Verweij; Henry F Vischer; Rob Leurs
Journal:  Mol Pharmacol       Date:  2018-09-24       Impact factor: 4.436

4.  Determining the potency and molecular mechanism of action of insurmountable antagonists.

Authors:  Terry Kenakin; Stephen Jenkinson; Christian Watson
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

5.  A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.

Authors:  Jia-Hui Wang; Xiao-Xia Shao; Meng-Jun Hu; Dian Wei; Ya-Li Liu; Zeng-Guang Xu; Zhan-Yun Guo
Journal:  Amino Acids       Date:  2017-02-04       Impact factor: 3.520

6.  Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925.

Authors:  Sean Conroy; Nicholas D Kindon; Jacqueline Glenn; Leigh A Stoddart; Richard J Lewis; Stephen J Hill; Barrie Kellam; Michael J Stocks
Journal:  J Med Chem       Date:  2018-03-28       Impact factor: 7.446

7.  Real-time analysis of the binding of fluorescent VEGF165a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes.

Authors:  Laura E Kilpatrick; Rachel Friedman-Ohana; Diana C Alcobia; Kristin Riching; Chloe J Peach; Amanda J Wheal; Stephen J Briddon; Matthew B Robers; Kris Zimmerman; Thomas Machleidt; Keith V Wood; Jeanette Woolard; Stephen J Hill
Journal:  Biochem Pharmacol       Date:  2017-04-07       Impact factor: 5.858

8.  Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to Rupatadine.

Authors:  Reggie Bosma; Zhiyong Wang; Albert J Kooistra; Nick Bushby; Sebastiaan Kuhne; Jelle van den Bor; Michael J Waring; Chris de Graaf; Iwan J de Esch; Henry F Vischer; Robert J Sheppard; Maikel Wijtmans; Rob Leurs
Journal:  J Med Chem       Date:  2019-07-05       Impact factor: 7.446

9.  Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human β1-adrenoceptor expressed in HEK-293 cells.

Authors:  Mark Soave; Leigh A Stoddart; Alastair Brown; Jeanette Woolard; Stephen J Hill
Journal:  Pharmacol Res Perspect       Date:  2016-08-08

10.  Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET.

Authors:  Diana C Alcobia; Alexandra I Ziegler; Alexander Kondrashov; Eleonora Comeo; Sarah Mistry; Barrie Kellam; Aeson Chang; Jeanette Woolard; Stephen J Hill; Erica K Sloan
Journal:  iScience       Date:  2018-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.